GUCY2C and colorectal carcinoma: Studies by Danaee noted that CRC tumour receptors tend to specifically over-express the Guanylyl cyclase C (GUCY2C) protein gene and stated that Anti-GCC monoclonal antibodies (mAbs) could be bound to NP-PS molecules, in order to enhance selective active targeting of CRC cells for enhanced PDT treatment [13].